The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial
Event:
ESC Congress 2018
Topic:
Cardiovascular Disease in the Elderly
Session:
The ageing heart: a target for interventions and aggressive pharmacotherapy